Riley maintains 'Buy' rating on LNTH but lowers price target; company faces profitability pressures.

From Yahoo Finance: 2025-06-29 21:58:00

Lantheus Holdings, Inc. (LNTH) is a top stock for a Growth Stock Portfolio. Riley maintains a ‘Buy’ rating on LNTH but lowers the price target from $122 to $109. The company faces profitability pressures despite revenue growth, as Q1 2025 revenue rose 0.8% YoY while adjusted EPS fell by 9.5% to $1.53.

LNTH is strategically making moves amid margin pressures, acquiring Evergreen Theragnostics and Life Molecular Imaging. The company plans to divest from its SPECT segment to SHINE Technologies to reinforce its PET-focused pipeline and strengthen its position in radiotherapeutics. LNTH is a developer of radiopharmaceutical and imaging solutions.

While LNTH shows investment potential, other AI stocks may offer greater upside with less downside risk. Consider exploring undervalued AI stocks that benefit from Trump-era tariffs and the onshoring trend. For more insights, check out the best short-term AI stock. No disclosure related to LNTH.

Read more: Riley Maintains ‘Buy’ Rating on Lantheus Holdings, Inc. (LNTH); Lowers PT